spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Roche 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 13 Sep 2024
Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2024
Caris Life Sciences Announces Appointment of Dave Fredrickson to Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 25 Jun 2024
Halozyme Announces Roche's OCREVUS(R) SC with ENHANZE(R) Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Devices Diagnostics FDA
 HSMN NewsFeed - 27 May 2024
Roche And Hitachi High-Tech Extend their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing
Diagnostics
 HSMN NewsFeed - 29 Mar 2024
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
Devices Radiology Personnel
 HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 1 Sep 2023
Zerion Pharma A/S appoints Mads Aaboe Jensen as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2023
VintaBio Names Jennifer Kingsley Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Mar 2023
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Jan 2023
ZyVersa Therapeutics Appoints Three New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2023
Blacksmith Medicines Announces Merger with Forge Therapeutics to Create Leading Company Developing Medicines Targeting Metalloenzymes
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Dec 2022
SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Nov 2022
Regulus Therapeutics Announces Appointments of Industry Veterans, Drs. Rekha Garg and Claire Padgett, to Lead Clinical Development, Regulatory and Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2022
Haystack Oncology Launches with $56 Million in Series A Financing to Accelerate Adoption of Post-Op Cancer Detection Technology and Optimize Cancer Therapy Monitoring and Treatment
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Nov 2022
Odyssey Therapeutics Expands Management Team with Key Appointments in Research Development and Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2022
Baylis Medical Technologies Signs Distribution Agreement with Oscor
Devices Interventional Distribution
 HSMN NewsFeed - 25 Aug 2022
3T Biosciences Debuts with $40 Million Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 18 Aug 2022
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 May 2022
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2022
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 30 Mar 2022
Pathalys Pharma Announces Executive Team Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics
 HSMN NewsFeed - 3 Jan 2022
Curis Adds Three New Executives to Management Team Strengthening Medical Affairs, Clinical Development and Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch
 HSMN NewsFeed - 23 Nov 2021
Smith & Nephew Launches 'Turn-Key' Robotic-Assisted Surgical System; Designed to Quickly Augment the Orthopaedic Team's Skills Set for Greater Accuracy(1-3)¥, Improved Outcomes(4), and Potentially an Immediate Scalable Solution to NHS
Devices Orthopaedic Surgery Product Launch
 HSMN NewsFeed - 22 Nov 2021
Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan(R)
Devices Gastroenterology Oncology
 HSMN NewsFeed - 19 Nov 2021
Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2021
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
Devices Dental Personnel
 HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Nov 2021
Argon Medical Launches Novel Innovations for Portal Vein Access Procedures
Devices Interventional Product Launch
 HSMN NewsFeed - 28 Oct 2021
Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Sep 2021
Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 3 Aug 2021
SynOx Therapeutics Further Strengthens Team with Appointments of Chief Medical Officer and Chief Technology Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jul 2021
SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jul 2021
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 23 Jun 2021
Evrysdi(TM) Approved in Japan for the Treatment of Spinal Muscular Atrophy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jun 2021
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(R) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 16 Jun 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 May 2021
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
Devices Endocrinology Product Launch
 HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 6 May 2021
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Apr 2021
Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Apr 2021
BD to Invest $65 Million for Key Supply Chain Infrastructure in Tucson, Arizona to Increase Resiliency of U.S. Medical Device Supply
Devices
 HSMN NewsFeed - 30 Mar 2021
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Mar 2021
Nuvalent Appoints Christopher Turner, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Mar 2021
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Mar 2021
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Diagnostics Oncology FDA
 HSMN NewsFeed - 23 Feb 2021
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2021
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Devices Monitoring Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2021
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jan 2021
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 19 Nov 2020
SynOx Therapeutics raises €37M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 30 Oct 2020
Sana Biotechnology Announces Acquisition of Oscine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2020
Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2020
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA(R) (Rituximab Injection) in China
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Oct 2020
Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 28 Sep 2020
Alligator Bioscience appoints Gayle Mills as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 19 Aug 2020
Apexigen Appoints Jakob Dupont to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Aug 2020
Sobi appoints Dr Ravi Rao as new Head of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 5 Jun 2020
Sosei Heptares Notes Phase IIIb ARGON Study With Enerzair(R) Breezhaler(R) (QVM149) Meets Primary Endpoint in Patients With Uncontrolled Asthma
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 May 2020
Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Apr 2020
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Apr 2020
Mesa Biotech Announces Ingo Chakravarty as President and CEO
Diagnostics Personnel
 HSMN NewsFeed - 26 Mar 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2020
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
Diagnostics Product Launch
 HSMN NewsFeed - 12 Mar 2020
AbbVie Receives European Commission Approval of VENCLYXTO(R) Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Mar 2020
Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Mar 2020
FDA Clears Next Generation HydroPICC from Access Vascular
Devices FDA
 HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Feb 2020
KAHR Medical Raises $18 Million in Private Funding Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Feb 2020
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Feb 2020
Pharvaris Appoints Peng Lu, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2020
Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2020
AbbVie Receives Positive CHMP Opinion for VENCLYXTO(R) as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Jan 2020
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 13 Jan 2020
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Jan 2020
Theragnostics Expands Team with Significant Appointments
Biopharmaceuticals Oncology Radiology Personnel
 HSMN NewsFeed - 8 Jan 2020
Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jan 2020
Martin Jönsson Appointed New CEO of AlzeCure Pharma
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Dec 2019
Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan(R) System
Devices Gastroenterology
 HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2019
Apexigen Expands Leadership Team with Two Key Appointments in CMC and Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Dec 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 4 Dec 2019
Accelerate Diagnostics Announces Executive Transition: Lawrence Mehren to Retire as Chief Executive Officer; Jack Phillips Appointed as Successor
Diagnostics Personnel
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces Clinical Trial Results of REVERSE-SD, a Phase 2b Study of Neflamapimod in Early-stage Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Nov 2019
Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic
Devices Neurology Venture Capital
 HSMN NewsFeed - 4 Nov 2019
Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 4 Nov 2019
Halozyme Announces Actions To Focus Strategy On ENHANZE(R) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Reduction in Force
 HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2019
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2019
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2019
Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2019
Biofourmis Names Two Pharmaceutical Veterans to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
Diagnostics FDA
 HSMN NewsFeed - 29 Jul 2019
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 19 Jul 2019
Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX(R) Utilizing ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery Regulatory
 HSMN NewsFeed - 16 Jul 2019
Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
Biopharmaceuticals Oncology Neurology
 HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2019
Pfizer to Acquire Array BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2019
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2019
Halozyme Announces argenx Has Selected Second Target Under ENHANZE(R) Technology Collaboration And License Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 May 2019
Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Apr 2019
LifeScan Names Brian Heald as its New Head of Product
Devices Diagnostics Personnel
 HSMN NewsFeed - 8 Apr 2019
F2G Appoints Dr. Patrick Vink as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2019
DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company's Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2019
Inovio Appoints Global Commercial Leader to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Feb 2019
BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Feb 2019
argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 29 Jan 2019
ViaCyte Announces New Board Members
Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2019
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
Devices Regenerative Medicine
 HSMN NewsFeed - 8 Jan 2019
Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2018
Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Dec 2018
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Dec 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Devices Radiology Venture Capital Personnel
 HSMN NewsFeed - 5 Dec 2018
Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 28 Nov 2018
FDA Approves Expanded Use for Ortho Clinical Diagnostics VITROS(R) HIV Combo Test
Devices Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 5 Nov 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2018
AbbVie Receives European Commission Approval of VENCLYXTO(R) (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Oct 2018
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Diagnostics FDA Product Launch
 HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Biopharmaceuticals Generics Oncology Regulatory
 HSMN NewsFeed - 17 Oct 2018
Akero Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 17 Sep 2018
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Sep 2018
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Sep 2018
Halozyme Appoints Bernadette Connaughton To Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Sep 2018
SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Aug 2018
GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Aug 2018
Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)
Diagnostics Oncology FDA
 HSMN NewsFeed - 8 Aug 2018
SQZ Biotech Completes Oversubscribed $72 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 Aug 2018
Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI(TM) in combination with MEKTOVI(R) and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Aug 2018
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 1 Aug 2018
IGM Biosciences Appoints Daniel S. Chen, M.D., Ph.D., as Chief Medical Officer; Names William Strohl, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2018
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 19 Jul 2018
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2018
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI(TM) (encorafenib) in Combination with MEKTOVI(R) (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jul 2018
Synthorx Expands Leadership Team with Three Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 2 Jul 2018
Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2018
BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello
Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Jun 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Jun 2018
Caris Life Sciences Expands Management Team
Diagnostics Personnel
 HSMN NewsFeed - 21 Jun 2018
Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
Diagnostics OB/GYN Personnel
 HSMN NewsFeed - 15 Jun 2018
AbbVie Announces New Undetectable Minimal Residual Disease Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of Venetoclax in Combination with Rituximab at 23rd European Hematology Association Annual Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2018
OrthoSensor, Inc. Secures Additional 510(K) Clearance
Devices Orthopaedic FDA
 HSMN NewsFeed - 11 Jun 2018
Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Devices Monitoring Product Launch
 HSMN NewsFeed - 7 Jun 2018
SutroVax Announces $85M Series C Financing led by TPG Growth
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 Jun 2018
IDEAYA Biosciences Appoints Paul Stone, J.D., as Senior Vice President and General Counsel, Head of Operations and Mark Lackner, Ph.D. as Vice President, Head of Biomarkers and Synthetic Lethal Biology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Jun 2018
Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 31 May 2018
Curis Announces FDA Fast Track Designation for Fimepinostat Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 May 2018
Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA
 HSMN NewsFeed - 7 May 2018
ORIC Has Appointed Jacob Chacko, MD as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 May 2018
Bausch & Lomb ULTRA(R) Contact Lenses Receive FDA Approval for Extended Wear Indication
Devices Ophthalmology FDA
 HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA
 HSMN NewsFeed - 11 Apr 2018
Macrophage Pharma Appoints Dr Michael Moore as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2018
Longhorn Vaccines and Diagnostics LLC receives de novo clearance by the U.S. Food and Drug Administration for PrimeStore(R) Molecular Transport Medium establishing a new class of microbial nucleic acid stabilization devices for molecular testing
Devices Diagnostics FDA
 HSMN NewsFeed - 8 Mar 2018
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Diagnostics FDA Product Launch
 HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Feb 2018
Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Feb 2018
ImmunoMet Appoints Vincent J. O'Neill, M.D., B.Sc., M.R.C.P, as Chief Medical Officer, and Allan L. Shaw as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Feb 2018
New Study Finds truFreeze(R) Spray Cryotherapy Less Painful than Radiofrequency Ablation for Treatment of Barrett's Esophagus Related Diseases
Devices Gastroenterology
 HSMN NewsFeed - 25 Jan 2018
BioPharma Veterans Launch New Oncology Company
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jan 2018
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 9 Jan 2018
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2018
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2018
H2-Pharma and CHEPLAPHARM Announce Re-Launch of XENICAL(R) Capsules
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 20 Dec 2017
ORIC Has Appointed Rich Heyman, PhD as Acting Chief Executive Officer and Leonard Reyno, MD as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Dec 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
Diagnostics Personnel
 HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 18 Dec 2017
Robert Stewart to Join Amneal Pharmaceuticals as President
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2017
Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
Oncology Personnel
 HSMN NewsFeed - 6 Dec 2017
Viriom Announces New Director Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2017
ResMed Elects Karen Drexler to its Board of Directors
Devices Personnel
 HSMN NewsFeed - 24 Oct 2017
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2017
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
Devices
 HSMN NewsFeed - 17 Oct 2017
Menlo Therapeutics Expands its Management Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2017
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2017
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Sep 2017
NCCN Guidelines to Include Categories of Preference
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 14 Sep 2017
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2017
Trial Results Show Astute Medical's NephroCheck Test With Guided Intervention Prevents Acute Kidney Injury, Shortens Hospital Stays And Reduces Costs
Diagnostics
 HSMN NewsFeed - 14 Aug 2017
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba(TM) in Germany, France and Austria
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Diagnostics Product Launch
 HSMN NewsFeed - 24 Jul 2017
CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jul 2017
NCCN Guidelines and NCCN Templates to be Integrated into ION Solutions' IntelliDoseTxM Treatment Management Module
Devices Oncology
 HSMN NewsFeed - 17 Jul 2017
Medicenna Bolsters Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 6 Jul 2017
Gail S. Page Joins Chembio Diagnostics Board of Directors
Diagnostics HIV/AIDS Personnel
 HSMN NewsFeed - 28 Jun 2017
Adicet Bio Appoints Jesse McGreivy, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jun 2017
Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2017
NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
Devices Oncology Radiology
 HSMN NewsFeed - 20 Jun 2017
Lannett Names Patrick G. LePore To Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 19 Jun 2017
Ocugen Makes Strategic Appointments to Management Team
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 15 Jun 2017
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2017
Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients
Diagnostics Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 May 2017
Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 May 2017
Churchill Pharmaceuticals Expands Commercial Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 May 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba(R) (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries
Biopharmaceuticals Distribution
 HSMN NewsFeed - 1 May 2017
FDA Clears Roche High-Volume Immunoassay Lab Testing Solution to Support Critical Medical Treatment Decisions
Diagnostics FDA
 HSMN NewsFeed - 26 Apr 2017
BD Licenses Novel Molecular Indexing Technology to Roche
Diagnostics Licensing
 HSMN NewsFeed - 24 Apr 2017
Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Apr 2017
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2017
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2017
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2017
Varian Medical Systems Names New CFO
Devices Oncology Personnel
 HSMN NewsFeed - 30 Mar 2017
Bausch & Lomb ULTRA(R) for Astigmatism Contact Lenses Introduced
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 29 Mar 2017
FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Mar 2017
SutroVax Announces Closing of $64M via Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Mar 2017
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 13 Mar 2017
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
Biopharmaceuticals Oncology Generics Licensing
 HSMN NewsFeed - 8 Mar 2017
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 24 Feb 2017
Xynomic Pharma Has Acquired Worldwide Rights of Abexinostat
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 10 Feb 2017
FDA Approves EMFLAZA(TM) (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jan 2017
Bellicum Announces Appointment of Rick Fair as Chief Executive Officer in Preparation for Commercialization of BPX-501 and Next Phase of Growth
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jan 2017
Juno Therapeutics Appoints Corsee D. Sanders as Executive Vice President and Head of Development Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Jan 2017
FDA Grants Priority Review for Genentech’s Actemra(R) (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jan 2017
Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
Devices Surgery Personnel
 HSMN NewsFeed - 4 Jan 2017
Corvus Pharmaceuticals Names Ian T. Clark, Former Genentech Chief Executive Officer, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2017
Ascletis Raises US$100 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Dec 2016
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
Biopharmaceuticals
 HSMN NewsFeed - 22 Dec 2016
Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS(TM) (Ocrelizumab) Published in New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Dec 2016
Northern Biologics, Mosaic Biomedicals Execute Transformative Deal
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 5 Dec 2016
Mission Therapeutics Appoints Colin Goddard as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2016
Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2016
Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 3 Nov 2016
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Nov 2016
Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 11 Oct 2016
FDA Grants Priority Review to Genentech’s Lucentis(R) (Ranibizumab Injection) Supplemental Biologics License Application for Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Sep 2016
Roche Receives 510(K) Clearance from FDA for Treponema Pallidum Assay to Aid Clinicians in the Diagnosis of Syphilis Infection
Diagnostics FDA
 HSMN NewsFeed - 23 Sep 2016
BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under Strategic Collaboration
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Sep 2016
Immune-Onc Therapeutics, Inc. Announces $7 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Sep 2016
Immune-Onc Therapeutics, Inc. Announces $7 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Aug 2016
Tioma Therapeutics Announces $86 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Aug 2016
AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Aug 2016
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
Biopharmaceuticals Acquisitions Product Launch
 HSMN NewsFeed - 1 Aug 2016
Roche receives CLIA waiver for cobas(R) Influenza A/B & RSV test for the cobas(R) Liat(R)
Diagnostics FDA
 HSMN NewsFeed - 27 Jul 2016
Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 27 Jul 2016
Pernix Therapeutics Announces Reorganization of Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2016
Genentech Provides Update on Phase III Study of Gazyva(R) in People With Previously Untreated Diffuse Large B-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jul 2016
Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2016
NEPHROCHECK(R) Test Predicts Acute Kidney Injury Risk In Sepsis Patients Including Those With Other Organ Failures
Diagnostics
 HSMN NewsFeed - 29 Jun 2016
Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Jun 2016
Merck to Acquire Afferent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Jun 2016
Personal Genome Diagnostics Names Abigail McElhinny Senior Vice President of Research & Development, Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA
 HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 6 May 2016
venBio Closes $315 Million Life Sciences Venture Capital Fund
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 May 2016
Eiger Bio Strengthens Senior Management Team with Announcement of Debra Odink, PhD as Senior Vice President of Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2016
Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2016
Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Apr 2016
DalCor Pharmaceuticals Completes $150 Million Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 18 Apr 2016
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2016
Joseph Horrigan Joins AMO Pharma as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2016
Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Apr 2016
FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer
Biopharmaceuticals Personalized Medicine Oncology FDA
 HSMN NewsFeed - 30 Mar 2016
Curis Announces Expansion of Executive Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Mar 2016
Roche Submits Filing to FDA For cobas(R) Procalcitonin (Pct) Assay to Help Clinicians Assess Response of Septic Patients to Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
Diagnostics FDA
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2016
AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Feb 2016
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 8 Feb 2016
Atlas Genetics Gains CE Approval for First Product
Diagnostics Regulatory
 HSMN NewsFeed - 2 Feb 2016
MISSION Therapeutics Raises £60 million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform
Biopharmaceuticals Oncology Neurology Venture Capital
 HSMN NewsFeed - 28 Jan 2016
Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA for the Combination Treatment of Patients with Untreated Acute Myeloid Leukemia not Eligible for Standard Induction Chemotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jan 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 Jan 2016
AbbVie's Venetoclax Receives Breakthrough Therapy Designation from FDA in Combination with Rituximab for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jan 2016
Oncimmune Appoints Greg Stanley as President of Commercial Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Jan 2016
Allakos Successfully Completes Dosing in Phase 1 Clinical Trial of AK001 and Announces Expansion of its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2016
Tensha Therapeutics To Be Acquired By Roche
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2016
C4 Therapeutics Enters Strategic Drug Discovery Collaboration in the Promising New Field of Targeted Protein Degradation
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2016
C4 Therapeutics Launches with $73 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 6 Jan 2016
OvaScience Names Harald F. Stock Chief Executive Officer-Elect
Devices Personnel
 HSMN NewsFeed - 5 Jan 2016
Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 5 Jan 2016
Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Dec 2015
Ignyta Appoints William Mccarthy as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Dec 2015
ProNAi Therapeutics Appoints Dr. Keith Anderson and Dr. Gregg Smith to its Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2015
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Nov 2015
First US Commercial Appointment: Atlas Genetics Appoints Keith Stauffer as VP Sales & Marketing
Diagnostics Personnel
 HSMN NewsFeed - 9 Nov 2015
Eiger BioPharmaceuticals Announces License Agreement with Nippon Kayaku to Develop Bestatin(TM) (ubenimex) for Inflammatory Diseases Involving LTB4
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2015
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
Devices Neurology
 HSMN NewsFeed - 4 Nov 2015
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Oct 2015
Adheron Therapeutics to be acquired by Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Oct 2015
Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma
Biopharmaceuticals Oncology Dermatology
 HSMN NewsFeed - 29 Sep 2015
Corvus Pharmaceuticals Completes $75 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2015
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 10 Sep 2015
Lori Kunkel, M.D., Joins Tocagen's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Sep 2015
U.S. FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2015
Ascletis Secures US$35 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Sep 2015
CeQur Announces $100 Million Series C Financing
Devices Drug Delivery Endocrinology Venture Capital
 HSMN NewsFeed - 27 Aug 2015
Greatbatch Signs Definitive Agreement to Acquire Lake Region Medical for $1.73 Billion
Devices Mergers & Acquisitions
 HSMN NewsFeed - 11 Aug 2015
Rich Pharmaceuticals, Inc. Appoints Richard Salvador, Ph.D., Research & Development Expert, To Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Aug 2015
FDA Approves Taro’s Keveyis(TM) (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2015
Metacrine Raises $36 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 Aug 2015
Hetero Announces the Launch of Biosimilar Rituximab (MABALL(TM)) in India
Biopharmaceuticals Generics Oncology Product Launch
 HSMN NewsFeed - 4 Aug 2015
Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2015
Intra-Cellular Therapies Expands Leadership Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Jul 2015
SutroVax raises $22 million in Series A
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Jul 2015
Ophthotech Announces New Senior Leadership Appointments
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 16 Jul 2015
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2015
In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People With a Specific Type of Bladder Cancer
Biopharmaceuticals Oncology Urology
 HSMN NewsFeed - 7 Jul 2015
Diadexus, Inc. Names William Hammond as Vice President of Sales
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 30 Jun 2015
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif(R)) in Two Phase III Studies in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jun 2015
Spero Completes $30 Million Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2015
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Diagnostics FDA
 HSMN NewsFeed - 14 May 2015
EPIRUS Biopharmaceuticals and mAbxience Sign Latin America Distribution Deal for Infliximab Biosimilar, BOW015
Biopharmaceuticals Distribution
 HSMN NewsFeed - 11 May 2015
Roche Receives FDA Approval for cobas(R) KRAS Mutation Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 17 Apr 2015
Accelerate Diagnostics Announces New Leadership Appointments
Diagnostics Personnel
 HSMN NewsFeed - 13 Apr 2015
Ultragenyx Appoints Daniel G. Welch to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2015
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 16 Mar 2015
Astute Medical, Inc. Previews International Intensive Care Meeting
Diagnostics
 HSMN NewsFeed - 19 Feb 2015
FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Feb 2015
Catabasis Names Rick Modi Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2015
Genentech’s Phase III Study of Gazyva(R) Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2015
U.S. FDA Grants Priority Review for YONDELIS(R) (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jan 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test
Diagnostics FDA
 HSMN NewsFeed - 13 Jan 2015
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2015
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Diagnostics
 HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel
 HSMN NewsFeed - 26 Nov 2014
Cardio3 BioSciences Announces the Nomination of Three Co-principal Investigators for its CHART-2 Phase III Clinical Trial of C-Cure(R) for the Treatment of Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 11 Nov 2014
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 Oct 2014
Elite Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2014
Navidea Announces Rick Gonzalez as New Chief Executive Officer
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 30 Sep 2014
WuXi PharmaTech Announces Appointment of William R. Keller to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2014
Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 Sep 2014
OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2014
Mylan Launches Generic Boniva(R) Injection
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 3 Sep 2014
BIND Therapeutics Appoints Two New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Aug 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Biopharmaceuticals Dermatology Venture Capital Personnel
 HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Aug 2014
MEDICREA’s K-JAWS(R) Obtains FDA Approval for Its Marketing in the United States
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jul 2014
Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf(R) (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jul 2014
Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack(R) model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2014
Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2014
Barry Lederman Appointed Vice President and Chief Financial Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2014
Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2014
Curis Announces Executive Management Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jun 2014
Uroplasty Strengthens Board of Directors with Addition of Kevin H. Roche
Devices Urology Personnel
 HSMN NewsFeed - 27 May 2014
Bristol-Myers Squibb and CytomX Therapeutics Announce Worldwide Collaboration to Develop Probody(TM) Therapeutics Against Multiple Immuno-Oncology Targets
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2014
Baxter Provides U.S. Regulatory Update on HyQvia, Its Investigational Subcutaneous Treatment for Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 May 2014
El Camino Hospital Installs Five Carestream DRX Imaging Systems to Perform Portable X-ray Exams at Two Campuses
Devices Radiology
 HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2014
Ventrus Biosciences to Merge With Assembly Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2014
Genkyotex Announces New Senior Management and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2014
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2014
Lysosomal Therapeutics Inc. Receives $4.8 Million in Seed Funding
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Apr 2014
Chugai Pharma USA Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 14 Apr 2014
Medicrea Announces European Launch of UNiD, the World’s First Patient-Specific Spinal Rod
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 9 Apr 2014
Patrick Roche, Ph.D. Joins HTG Molecular Diagnostics
Diagnostics Personnel
 HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 8 Apr 2014
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 7 Apr 2014
Alios BioPharma Raises $41 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Mar 2014
Xenon and Genentech Establish New Pain Discovery Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2014
Volcano Announces FDA Clearance of its Proprietary iFR(R) (instant wave-Free Ratio(TM)) Modality and Immediate Commencement of U.S. Limited Market Release
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 18 Mar 2014
Immune Design Appoints Franklin M. Berger to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Mar 2014
Caliber Imaging & Diagnostics Names Robert T. Kelley to Vice President of U.S. Sales
Devices Radiology Personnel
 HSMN NewsFeed - 3 Mar 2014
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
Regenerative Medicine Personnel
 HSMN NewsFeed - 3 Mar 2014
Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Feb 2014
ImmunoGen, Inc. Appoints Ellie Harrison as Chief Human Resources Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2014
PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Feb 2014
Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 31 Jan 2014
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jan 2014
Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium
Diagnostics Oncology
 HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Biopharmaceuticals Neurology Cardiology Personnel
 HSMN NewsFeed - 24 Jan 2014
PTC Therapeutics Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2014
LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 16 Jan 2014
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2014
Caliber Imaging & Diagnostics Receives $1.4 Million Order for VivaScope(R) Systems From European Distributor MAVIG GmbH
Devices Oncology Distribution
 HSMN NewsFeed - 13 Jan 2014
Seattle Genetics Appoints John A. Orwin to Board of Directors
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Agenus Appoints Robert B. Stein, MD, PhD, as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Jan 2014
CytomX Therapeutics and ImmunoGen, Inc. Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jan 2014
Teva Names Erez Vigodman as President and CEO
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 8 Jan 2014
Sorrento Therapeutics Appoints Amar Singh as Executive Vice President and Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Lipocine Announces New Appointments to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Jan 2014
Beth Israel Deaconess Medical Center Uses Carestream’s DRX Systems to Enhance Diagnosis, Treatment of Critical Care Patients
Devices Radiology
 HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2014
Marina Biotech and Mirna Therapeutics Amend License Agreement for the Development of microRNA-Based Therapeutics
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 Dec 2013
ImmunoGen, Inc. Appoints David Johnston as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Dec 2013
OncoSec Medical Announces Hire of Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Dec 2013
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2013
Getinge Group Appoints Harald F. Stock as New President and CEO of ArjoHuntleigh and Executive Vice President Extended Care Business Area
Devices Personnel
 HSMN NewsFeed - 5 Dec 2013
Savara Pharmaceuticals Appoints Two New Members to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Dec 2013
TherapeuticsMD Appoints Joel S. Krasnow, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 27 Nov 2013
Atlas Appoints David Whitaker as Operations Director
Diagnostics Personnel
 HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 21 Nov 2013
Eloxx Pharmaceuticals, Ltd. Announced the Initial Closing of its First Round of Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2013
ImmunoGen, Inc. Announces Approval of Roche’s Kadcyla(R) in the European Union
Biopharmaceuticals Drug Delivery Oncology Regulatory
 HSMN NewsFeed - 14 Nov 2013
Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2013
FDA Approves Gazyva (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Oct 2013
Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Devices Drug Delivery Monitoring Endocrinology FDA
 HSMN NewsFeed - 11 Oct 2013
FDA Files Genentech’s Supplemental Biologics License Application of Xolair(R) (omalizumab) for Chronic Idiopathic Urticaria (CIU)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Devices Monitoring Cardiology Regulatory
 HSMN NewsFeed - 9 Oct 2013
Novelos Appoints Industry Veteran to Lead Strategic Realignment
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 26 Sep 2013
Relypsa Adds Renal Industry Veteran John P. Butler to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2013
Rochester General Health System Installs Masimo Patient SafetyNet(TM) for Advanced Care and Oversight of Patients
Devices Monitoring
 HSMN NewsFeed - 4 Sep 2013
SANUWAVE Appoints Life Sciences Industry Executive, Alan L. Rubino To Its Board
Devices Wound Care Personnel
 HSMN NewsFeed - 4 Sep 2013
Bard Announces Agreement to Acquire Rochester Medical, Inc.
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 28 Aug 2013
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2013
ImmunoGen, Inc. Announces Executive Change
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2013
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 26 Jul 2013
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Jul 2013
Adimab Announces First Antibody Technology Transfer and License Agreement with GlaxoSmithKline
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jul 2013
Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jul 2013
Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System(TM)
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 19 Jul 2013
Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jul 2013
FDA Grants Genentech’s Obinutuzumab (GA101) Priority Review for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2013
FDA Grants Genentech’s Perjeta Regimen Priority Review for Use Before Surgery in HER2-Positive Early Stage Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jun 2013
Middle Peak Medical Raises $8.5 M to Develop Novel Mitral Valve Technology
Devices Cardiology Venture Capital
 HSMN NewsFeed - 18 Jun 2013
John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2013
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
Diagnostics Personnel
 HSMN NewsFeed - 31 May 2013
Plexxikon Announces Program Update and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 May 2013
Curis Announces Approval of Erivedge(R) in Australia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Apr 2013
Sorin Group Receives Conditional FDA Approval to Conduct IDE Clinical Trial for Perceval (TM) S Sutureless Aortic Valve in the United States
Devices Cardiology FDA
 HSMN NewsFeed - 29 Apr 2013
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2013
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Mar 2013
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 21 Mar 2013
MEDICREA Receives FDA Pediatric Clearance for PASS(R) LP Systems
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 19 Mar 2013
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
Diagnostics Oncology Personnel
 HSMN NewsFeed - 13 Mar 2013
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 11 Mar 2013
MacuLogix Raises $3.6 Million in Series A Round
Diagnostics Ophthalmology Venture Capital
 HSMN NewsFeed - 11 Mar 2013
NovaBay Names Keith Bley as Senior Vice President of Product Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Roche
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.